Capecitabine is indicated for the treatment of patients with metastatic breast cancer resistant to both paclitaxel and an anthracycline-containing chemotherapy regimen or resistant to paclitaxel and for whom further anthracycline therapy is not indicated.
Composition
NEUCAP 500
Each film coated tablet contains:
Capecitabine I.P. 500mg
NEUCAP150
Each film coated tablet contains:
Capecitabine I.P. 150 mg
INDICATIONS AND USAGE
Capecitabine is indicated for the treatment of patients with metastatic breast cancer resistant to both paclitaxel and an anthracycline-containing chemotherapy regimen or resistant to paclitaxel and for whom further anthracycline therapy is not indicated.
Key attributes
Category
Oncology
Model number
NEUCAP
Place of origin
Bangalore, KA, India
HSN code
3004
Reviews
Questions & answers
Ask the supplier — answers are visible to all buyers